Home/Filings/4/0000885590-26-000003
4//SEC Filing

Paulson John 4

Accession 0000885590-26-000003

CIK 0000885590other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:08 PM ET

Size

6.5 KB

Accession

0000885590-26-000003

Insider Transaction Report

Form 4
Period: 2025-12-31
Paulson John
Director
Transactions
  • Award

    Common Shares, No Par Value

    2025-12-31+8,992360,120 total
Holdings
  • Common Shares, No Par Value

    (indirect: By Managed Funds)
    73,255,869
Footnotes (2)
  • [F1]Reflects Restricted Share Units issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2025, each representing a contingent right to receive one common share, no par value, of the Issuer.
  • [F2]John Paulson, the controlling person of Paulson Capital Inc. ("Paulson"), serves on the board of directors of the Issuer. Paulson is the investment manager of investment funds (the "Funds"). John Paulson may be deemed an indirect beneficial owner of the securities, which are directly owned by the Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Act"), the reporting person disclaims beneficial ownership of any securities reported herein, except to the extent that the reporting person has a pecuniary interest therein. This report shall not be deemed an admission that such reporting person is the beneficial owner of any securities not directly owned by such reporting person.

Issuer

Bausch Health Companies Inc.

CIK 0000885590

Entity typeother

Related Parties

1
  • filerCIK 0001394923

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:08 PM ET
Size
6.5 KB